Atlas Trials

Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy

Clinical trial NCT05951699 · UNKNOWN

Trial details

NCT number
NCT05951699
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Cancer
Start date
2022-04-28
Primary completion
2025-12-31
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.